EICHORCondition: Crohn's Disease · Sponsor: Takeda
CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, Arizona, United States | — |
| VA Loma Linda Healthcare System | Loma Linda, California, United States | — |
| United Medical Doctors | Murrieta, California, United States | — |
| University of Southern California Medical Center | Newport Beach, California, United States | — |
| Clinnova Research Solutions | Orange, California, United States | — |
| University of California at Irvine Medical Center | Orange, California, United States | — |
| Kaiser Permanate of Colorado | Aurora, Colorado, United States | — |
| Medical Research Center of Connecticut, LLC | Hamden, Connecticut, United States | — |
| West Central Gastroenterology d/b/a Gastro Florida | Clearwater, Florida, United States | — |
| Gastroenterology Associates of Pensacola, PA | Pensacola, Florida, United States | — |
| Grand Teton Research Group, PLL | Idaho Falls, Idaho, United States | — |
| GI Alliance | Arlington Heights, Illinois, United States | — |
+ 32 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04809363